Precision Delivery Transforms Results: Oncology Expanded Access Case Study A large, multi-national pharmaceutical company wanted to run an expanded access program to collect safety data for their colorectal cancer drug after obtaining positive results in Phase III. The trial was to include 25 countries with an open-ended target of 2500-3000 patients. Understanding the Challenge ? Increased pressure for site activation and recruitment so pat

Join for free to read